Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 12781446)

1.

THY1 expression is associated with tumor suppression of human ovarian cancer.

Abeysinghe HR, Cao Q, Xu J, Pollock S, Veyberman Y, Guckert NL, Keng P, Wang N.

Cancer Genet Cytogenet. 2003 Jun;143(2):125-32.

PMID:
12781446
2.

The role of the THY1 gene in human ovarian cancer suppression based on transfection studies.

Abeysinghe HR, Pollock SJ, Guckert NL, Veyberman Y, Keng P, Halterman M, Federoff HJ, Rosenblatt JP, Wang N.

Cancer Genet Cytogenet. 2004 Feb;149(1):1-10.

PMID:
15104276
3.

Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11.

Cao Q, Abeysinghe H, Chow O, Xu J, Kaung H, Fong C, Keng P, Insel RA, Lee WM, Barrett JC, Wang N.

Cancer Genet Cytogenet. 2001 Sep;129(2):131-7.

PMID:
11566343
4.

[Growth inhibitory effects of THY1 gene on epithelial ovarian cancer SKOV3 cells].

Zeng LQ, Peng ZL.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jan;27(1):84-7, 91. Chinese.

5.

THY-1 induction is associated with up-regulation of fibronectin and thrombospondin-1 in human ovarian cancer.

Abeysinghe HR, Li LQ, Guckert NL, Reeder J, Wang N.

Cancer Genet Cytogenet. 2005 Sep;161(2):151-8.

PMID:
16102586
6.

Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.

Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, Stanbridge EJ, Lung ML.

Int J Cancer. 2010 Jul 15;127(2):304-12. doi: 10.1002/ijc.25047.

PMID:
19921696
7.

Regulator of G-protein signalling expression and function in ovarian cancer cell lines.

Hurst JH, Mendpara N, Hooks SB.

Cell Mol Biol Lett. 2009;14(1):153-74. doi: 10.2478/s11658-008-0040-7. Epub 2008 Oct 31.

PMID:
18979070
8.

Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.

Rider MA, Butz GM, Ricketts SL, Newberry ST, Grisham JW, Coleman WB.

Int J Oncol. 2002 Feb;20(2):235-45.

PMID:
11788883
9.

Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.

Lamendola DE, Duan Z, Yusuf RZ, Seiden MV.

Cancer Res. 2003 May 1;63(9):2200-5.

10.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.

Cancer Res. 2007 Aug 1;67(15):7095-105.

11.

Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H, Ringuette MJ.

Gynecol Oncol. 1999 Oct;75(1):25-33.

PMID:
10502421
12.

Screening for genes associated with ovarian cancer prognosis.

Chang XH, Zhang L, Yang R, Feng J, Cheng YX, Cheng HY, Ye X, Fu TY, Cui H.

Chin Med J (Engl). 2009 May 20;122(10):1167-72.

PMID:
19493465
13.
14.

Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.

Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI.

Cancer Res. 2002 Jan 1;62(1):262-70.

15.

Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.

Seitz S, Korsching E, Weimer J, Jacobsen A, Arnold N, Meindl A, Arnold W, Gustavus D, Klebig C, Petersen I, Scherneck S.

Genes Chromosomes Cancer. 2006 Jun;45(6):612-27.

PMID:
16552773
16.

Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.

Kruzelock RP, Cuevas BD, Wiener JR, Xu FJ, Yu Y, Cabeza-Arvelaiz Y, Pershouse M, Lovell MM, Killary AM, Mills GB, Bast RC Jr.

Oncogene. 2000 Dec 14;19(54):6277-85.

17.

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD.

Cancer Res. 2000 Dec 1;60(23):6744-9.

18.

Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.

Xu S, Mou H, Gu L, Su D, Zhu C, Liu X.

J Genet Genomics. 2007 Jul;34(7):581-90.

PMID:
17643943
19.

Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.

Liu Y, Emilion G, Mungall AJ, Dunham I, Beck S, Le Meuth-Metzinger VG, Shelling AN, Charnock FM, Ganesan TS.

Oncogene. 2002 Jan 17;21(3):387-99.

20.

Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis.

Yamanaka S, Sunamura M, Furukawa T, Sun L, Lefter LP, Abe T, Yatsuoka T, Fujimura H, Shibuya E, Kotobuki N, Oshimura M, Sakurada A, Sato M, Kondo T, Matsuno S, Horii A.

Lab Invest. 2004 Oct;84(10):1339-51.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk